Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

January 24, 2025

Primary Completion Date

September 19, 2025

Study Completion Date

December 12, 2025

Conditions
Obesity or Overweight
Interventions
DRUG

RGT001-075

RGT001-075 is a small molecule GLP-1 agonist

DRUG

Placebo Comparator

Placebo comparator

Trial Locations (35)

13850

Velocity Clinical Research, Vestal

20854

Velocity Clinical Research, Rockville

27701

Velocity Clinical Research, Durham

28287

Javara-Tryon Medical Partners, PLLC, Charlotte

31406

Javara-Privia Medical Group, Georgia LLC, Savannah

31792

Javara-Privia Medical Group, Georgia, LLC, Thomasville

32162

Synexus Clinical Research, The Villages

32934

Optimal Research, Melbourne

33014

Palm Springs Community Health Center, Miami Lakes

33122

Angels Clinical Research, Doral

33126

Angels Clinical Research, Miami

36608

Alliance for Multispecialty Research, LLC, Mobile

40509

Alliance for Multispecialty Research, LLC, Lexington

44122

Velocity Clinical Research, Cleveland

45246

Velocity Clinical Research, Cincinnati

46383

Velocity Clinical Research, Valparaiso

47714

Synexus Clinical Research, Evansville

55423

Synexus Clinical Research, Richfield

56001

Mankato Clinic-East Main Street-Javara, Mankato

63141

Synexus Clinical Research, Creve Coeur

68134

Velocity Clinical Research, Omaha

70809

Velocity Clinical Research, Baton Rouge

73069

Alliance for Multispecialty Research, LLC, Norman

75230

Velocity Clinical Research, Dallas

75234

Synexus Clinical Research, Dallas

76710

Velocity Clinical Research, Waco

77384

Javara-Privia Medical Group Gulf Coast PLLC, The Woodlands

78229

Synexus Clinical Research, San Antonio

84088

Velocity Clinical Research, West Jordan

84106

Synexus Clinical Research, Salt Lake City

85020

Synexus Clinical Research, Phoenix

90255

Velocity Clinical Research, Huntington Park

98105

Velocity Clinical Research, Seattle

07871

Premier Health Research-Sparta-Objective Health, Sparta

02818

Velocity Clinical Research, East Greenwich

All Listed Sponsors
lead

Regor Pharmaceuticals Inc.

INDUSTRY

NCT06867718 - Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions | Biotech Hunter | Biotech Hunter